The conversation has opened up and that is powerful.
Women are speaking more honestly about menopause than ever before. Symptoms are being recognised. Experiences are being shared. Silence is slowly being replaced with visibility.
But here is what is not changing fast enough.
Scroll your phone for five minutes and menopause will find you.
Cooling bracelets. Hormone-balancing teas. Serums for “menopause skin.” Supplements promising calm, sleep, focus, libido, sometimes all at once. If you have ever thought “Should I try this?” you are not alone.
But this week, doctors, researchers and clinicians across the UK and US have raised a red flag. Menopause has become a marketing gold rush and women are paying the price.
What happens when the policies designed to support you were never written with you in mind?
Across the UK, research from the Fawcett Society shows that 1 in 10 women have left their jobs due to menopause symptoms, with many more reducing their hours or stepping back from leadership roles.
The Chartered Institute of Personnel and Development (CIPD) found:
3 in 5 menopausal women are negatively affected at work
1. KNOW YOUR BODY, IT IS NOT "JUST ANXIETY" Brain fog, night sweats, poor concentration, mood changes, these are menopause symptoms, not weakness. Learn the signs early. Your body is speaking. Listen to it before the system silences you.
2. EDUCATE YOURSELF BEFORE CRISIS HITS Don't wait until symptoms are unbearable. Seek out menopause education in your 30s, not your 50s. Knowledge is your first line of defence.
3. WALK INTO THAT APPOINTMENT PREPARED Write your symptoms down. Know your options, including HRT. Go in informed, because too many of us have been sent away with antidepressants we didn't need.
4. REFUSE TO BE DISMISSED If a doctor tells you you're "too young" or "It is probably stress", push back. Ask for a referral. Seek a second opinion. You know your body. Demand to be heard.
Menopause care has advanced. Awareness is higher. Prescriptions are rising. Yet many women still report inconsistent results from HRT, limited follow-up and uncertainty about whether their treatment is truly personalised.
In 'Beyond One-Size HRT', we examine a critical question in modern women’s health:
Are we still applying a standardised hormone therapy model to biologically diverse women?
Leading authourities including the North American Menopause Society, NICE and the British Menopause Society are clear. Hormone replacement therapy should be individualised based on age, timing since menopause, cardiovascular risk, symptom profile and medical history.
Menopause affects over 13 million women in the UK, yet diagnosis delays, unequal access to care and stigma still undermine women’s health and careers.
AI is rapidly reshaping the landscape; speeding diagnosis, personalising care and exposing inequities that traditional systems have overlooked. Crucially, to deliver real benefits for Black and women of colour, AI systems must be trained on diverse data and evaluated for bias at every step.
For decades, menopause research has lacked both scale and representation. Globally, nearly 85% of women experience menopause-related symptoms, yet conventional research has struggled to capture the biological and social complexity of the transition.
Menopause is often spoken about as if it arrives at the same time, in the same way, for every woman.
For many Black women and women of colour, that assumption does real harm. Early and surgical menopause are not rare outliers, they are lived realities shaped by stress, health inequalities and systems that were never designed with our bodies in mind.
Menopause is already a profound physiological and psychological transition. Hormones shift, sleep fractures, cognition feels unreliable, emotions intensify, joints ache, confidence wobbles. Yet for Black and South Asian women, menopause is rarely permitted to exist as a legitimate medical event. It is filtered instead through disbelief, misinterpretation and systemic minimisation.
The data now confirms what women have been saying quietly for years. Analysis of prescription records covering 1.85 million women in the UK shows that while 23.3 percent of white women are prescribed Hormone Replacement Therapy, only around 5 to 5.2 percent of Black women and 6 to 6.2 percent of Asian women receive the same treatment.
Lupus is often spoken about as a “rare” condition, yet the numbers tell a different story when you look closely at who is most affected and when symptoms peak. In the United States, more than 200,000 people are estimated to have systemic lupus erythematosus (SLE) and women make up the overwhelming majority of cases. In the United Kingdom, large-scale primary care data show SLE incidence around 5.47 per 100,000 person-years and prevalence has risen over time.
Now layer menopause on top. The midlife transition that already carries its own burden of disrupted sleep, joint pain, mood changes, brain fog and rising cardiovascular risk. For women living with lupus, menopause is not simply “a phase”. It can be a turning point that changes symptom patterns, complicates treatment choices and exposes health inequities that have been present all along.
A decade-long study suggests tea may support bone density in older women, while heavy coffee intake is linked to lower bone density after menopause. On its own, that is interesting.
But when you factor in what we know about earlier menopause, bone health risk and unequal access to menopause care for Black and South Asian women, this research takes on a deeper significance.
Menopause is not just a hormonal transition. It affects bone remodelling, inflammation, muscle strength, balance and long-term mobility. For women who enter menopause earlier, these changes begin sooner and last longer. When musculoskeletal symptoms are under-recognised or normalised, the long-term impact is often missed until later life.
We often talk about menopause as if it is an ending. But in truth, it is a turning point, a recalibration of the body’s chemistry, rhythm and sense of identity.
One of the most visible and misunderstood signs of this transition is hair loss. By age 50, over 40% of women experience noticeable thinning, yet most are told it is “just part of aging.” Science tells a different story.
What is really happening is a hormonal imbalance, not a slow decay. During menopause, estrogen and progesterone, the two hormones that nurture, protect and sustain hair follicles, begin to fall. Their decline leaves hair unprotected from a more dominant hormone called DHT (dihydrotestosterone), which miniaturises follicles and slows growth. In other words, it is not time that is taking your hair. It is chemistry.
In every doctor’s office, there is a quiet vocabulary that determines how women’s pain is recorded, treated or dismissed.
Words like dysmenorrhea, menorrhagia and amenorrhea are not just medical jargon, they are signals, codes that unlock care or close the door to it. Yet who gets to use these words and who gets heard when they do, tells a bigger story about health inequity than most of us realise.
Behind each clinical term lies a lived reality, an experience that reaches far beyond a line in a medical textbook. These words describe the rhythms and disruptions that can shape a woman’s physical, emotional and professional life.
Proud Sista!
Proud Sista!
Proud Sista!
Proud Sista!
Proud Sista!
